Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for CMPX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 24.12M
March 31, 2026 18.70M
December 31, 2025 25.36M
September 30, 2025 21.65M
June 30, 2025 23.49M
March 31, 2025 21.17M
December 31, 2024 15.17M
September 30, 2024 10.75M
June 30, 2024 9.507M
March 31, 2024 4.082M
December 31, 2023 8.337M
September 30, 2023 9.993M
June 30, 2023 10.90M
March 31, 2023 12.71M
Date Value
December 31, 2022 18.01M
September 30, 2022 11.72M
June 30, 2022 13.33M
March 31, 2022 12.07M
December 31, 2021 13.68M
September 30, 2021 11.01M
June 30, 2021 12.00M
March 31, 2021 14.73M
December 31, 2020 11.97M
September 30, 2020 13.40M
June 30, 2020 17.20M
March 31, 2020 147.04M
December 31, 2019 148.98M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Upstream Bio, Inc. 10.21M
ACADIA Pharmaceuticals, Inc. 436.29M
Alnylam Pharmaceuticals, Inc. 4.205B
Anika Therapeutics, Inc. 46.19M
Savara, Inc. 48.48M

Total Liabilities (Quarterly) Related Metrics